NextCure, Inc. - Common Stock, $0.001 par value per share (NXTC) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2025 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
NXTC on Nasdaq
Shares outstanding
3,633,984
Price per share
$10.70
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
1,897,561
Total reported value
$26,925,657
% of total 13F portfolios
0%
Share change
+824,352
Value change
+$12,224,139
Number of holders
24
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NextCure, Inc. - Common Stock, $0.001 par value per share (NXTC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Ikarian Capital, LLC 10% $4,715,825 363,035 Ikarian Capital, LLC 31 Dec 2025
Affinity Asset Advisors, LLC 10% +40% $4,375,018 +$1,966,899 348,607 +82% Affinity Asset Advisors, LLC 22 Jan 2026
Simcere Zaiming, Inc. 13% $1,696,566 338,636 Simcere Zaiming, Inc. 20 Jun 2025
Squadron Capital Management LLC 9.9% +49% $3,521,940 +$1,263,485 271,127 +56% Squadron Master Fund LP 31 Dec 2025
SILVERARC CAPITAL MANAGEMENT, LLC 5% $2,286,980 176,057 SilverArc Capital Management, LLC 31 Dec 2025

As of 31 Dec 2025, 24 institutional investors reported holding 1,897,561 shares of NextCure, Inc. - Common Stock, $0.001 par value per share (NXTC). This represents 52% of the company’s total 3,633,984 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of NextCure, Inc. - Common Stock, $0.001 par value per share (NXTC) together control 52% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Affinity Asset Advisors, LLC 6.8% 247,294 +29% 0.25% $3,509,102
Ikarian Capital, LLC 6.6% 238,303 0.44% $3,381,520
Squadron Capital Management LLC 6.5% 236,966 0% 1.5% $3,362,548
Sofinnova Investments, Inc. 6.1% 222,654 0% 0.14% $3,159,460
SILVERARC CAPITAL MANAGEMENT, LLC 4.8% 176,057 0.36% $2,498,249
Exome Asset Management LLC 4.5% 165,000 1.2% $2,341,350
Pfizer Inc 4.3% 157,646 0% 0.95% $2,236,997
AWM Investment Company, Inc. 3.2% 117,371 0.16% $1,665,494
VANGUARD GROUP INC 2.5% 91,910 +35% 0% $1,304,203
BOOTHBAY FUND MANAGEMENT, LLC 1.9% 69,617 0.03% $987,865
RENAISSANCE TECHNOLOGIES LLC 0.93% 33,634 +19% 0% $477,266
BlackRock, Inc. 0.76% 27,793 -11% 0% $394,383
ACADIAN ASSET MANAGEMENT LLC 0.74% 26,765 -27% 0% $379,000
GEODE CAPITAL MANAGEMENT, LLC 0.64% 23,157 +19% 0% $328,660
CARDIFF PARK ADVISORS, LLC 0.6% 21,833 0.03% $309,810
MILLENNIUM MANAGEMENT LLC 0.36% 13,033 0% $184,938
MARSHALL WACE, LLP 0.31% 11,292 0% $160,233
Sio Capital Management, LLC 0.3% 10,940 0% 0.03% $155,239
BARCLAYS PLC 0.15% 5,626 0% 0% $79,833
UBS Group AG 0.01% 338 -44% 0% $4,796
BANK OF AMERICA CORP /DE/ 0% 173 +652% 0% $2,454
MORGAN STANLEY 0% 66 0% $937
JPMORGAN CHASE & CO 0% 61 0% 0% $866
BNP PARIBAS FINANCIAL MARKETS 0% 32 0% 0% $454
Cable Car Capital, LP 0% 0 -100% $0

Institutional Holders of NextCure, Inc. - Common Stock, $0.001 par value per share (NXTC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,897,561 $26,925,657 +$12,224,139 $14.19 24
2025 Q3 836,243 $4,898,495 +$4,898,307 $5.86 16